首頁 > 市場調查報告書 > 醫療設備

手術用器具

市場調查報告書

商品編碼

1656906

吻合口漏設備:市場洞察·競爭情形·市場預測 (～2032年)

Anastomotic Leak Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

出版日期: 2025年01月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

吻合口漏裝置市場規模預計將從 2024 年的 34.4284 億美元增長到 2032 年的 52.9462 億美元，預測期內的複合年增長率為 5.59%。

由於大腸直腸癌和冠狀動脈疾病 (CAD) 盛行率上升、監管部門批准增加以及胃腸手術數量增加，吻合口漏裝置市場正在經歷顯著增長。

吻合口漏裝置市場動態：

根據2024年全球癌症觀察站的數據，2022年全球大腸直腸癌病例總數約為1,926,425例。數據進一步顯示，亞洲佔總數的近50％，為966,399例，其次是歐洲，為538,262例。全球大腸直腸癌發生率高，推動了外科治療的需求，吻合口滲漏裝置在腸道切除和重新連接中發揮關鍵作用。這些設備已成為大腸直腸癌手術中不可或缺的設備，因為它們可以提高手術精度、減少併發症、改善患者治療效果，從而增加其在市場上的佔有率。

根據英國心臟基金會的《全球心臟和循環系統疾病情況說明書》（2024 年），目前全球約有 2 億人被診斷出患有 CAD。吻合口漏裝置在 CAD 治療中變得越來越重要，因為它們可以提高冠狀動脈繞道手術 (CABG) 等手術的準確性和效率，改善患者預後並減少併發症。

基於可用性，可重複使用部分預計將在 2024 年佔據主要收入佔有率。這主要是因為製造商對開發技術先進的可重複使用的吻合口漏裝置的興趣日益濃厚，以實現高效的血管連接以及該領域提供的各種其他益處。

可重複使用的吻合口漏裝置可為患有心血管和胃腸道疾病的患者提供快速放置、最小組織反應、低感染風險和強力傷口閉合。此外，可重複使用的吻合口漏裝置有多種形狀和尺寸，以方便手術期間的閉合過程。

本報告提供全球吻合口漏設備的市場調查，彙整市場概要，市場影響因素及市場機會分析，法律制度，市場規模的轉變·預測，各種區分·地區/各主要國家的詳細分析，競爭情形，主要企業簡介等資訊。

Anastomotic Leak Devices Market by Usability (Disposable and Reusable), Application (Cardiovascular Surgery, Gastrointestinal Surgery, and Others), End-User (Hospitals, Speciality Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2032 owing to the increasing number of chronic disorders and the rising product developmental activities worldwide

The anastomotic leak devices market was valued at USD 3,442.84 million in 2024, growing at a CAGR of 5.59% during the forecast period from 2025 to 2032 to reach USD 5,294.62 million by 2032. The anastomotic leak devices market is growing significantly due to the increasing cases of colorectum cancers, and coronary artery disease (CAD) among the population, increasing clearances from regulatory bodies, growing number of gastrointestinal surgeries, among others that are expected to escalate the overall growth of the anastomotic leak devices market during the forecast period from 2025 to 2032.

Anastomotic Leak Devices Market Dynamics:

Data from the Global Cancer Observatory 2024, stated that in 2022, there were about 1,926,425 total cases of colorectum cancer worldwide. The same source further stated that Asia accounted for 966,399 colorectum cancer cases, comprising almost 50% of the total cases, and Europe accounted for 538,262 colorectum cancer cases. The high incidence of colorectal cancer globally drives the demand for surgical treatments, where anastomotic leak devices play a critical role in resecting and reconnecting the colon. These devices enhance surgical precision, reduce complications, and improve patient outcomes, making them indispensable in colorectal cancer surgeries and expanding their market presence.

According to British Heart Foundation, Global Heart & Circulatory Diseases Factsheet (2024), it stated that around 200 million people are currently living with CAD around the world. Anastomotic leak devices enhance precision and efficiency in procedures like coronary artery bypass grafting (CABG), improving patient outcomes and reducing complications, making them increasingly integral to CAD treatment.

Increased product development activities by regulatory bodies are also slated to witness market growth for anastomotic leak devices. For example, in January 2023, Lydus Medical announced that its Vesseal microvascular anastomosis suture deployment system received 510(k) clearance from the US Food and Drug Administration (FDA).

Hence, the interplay of all the above-mentioned factors is expected to drive the market for anastomotic leak devices market during the given forecast period from 2025 to 2032.

However, the risk of postoperative complications such as tissue irritation, infection, pressure necrosis, and others may limit their end-user base, thus acting as key constraints limiting the growth of the anastomotic leak devices.

Anastomotic Leak Devices Market Segment Analysis:

In the usability segment of the anastomotic leak devices market, the reusable category is expected to have a significant revenue share in the year 2024. This is primarily owing to the rising focus of manufacturers towards developing technologically advanced reusable anastomotic leak devices for improved and efficient connection of vessels and the other various advantages offered by the category.

The reusable anastomotic leak devices provide quick placement, minimal tissue reaction, low risk of infection, and strong wound closure in patients with cardiovascular and gastrointestinal diseases. The reusable anastomotic leak devices are also available in different shapes and sizes, easing the process of closure during surgery.

Further, the increasing product launches and regulatory approvals for reusable anastomotic leak devices will aid in increasing their market demand. For instance, in March 2021, the FDA approved Viola clamps, a less proximal anastomotic leak device, and a new device for clamp proximal anastomosis in coronary artery bypass grafting (CABG).

Therefore, owing to the aforementioned factors, the reusable anastomotic leak devices category is expected to witness considerable growth eventually contributing to the overall growth of the global anastomotic leak devices market during the forecast period.

North America is expected to dominate the overall Anastomotic Leak Devices market:

Among all the regions, North America is estimated to hold a significant revenue share in the anastomotic leak devices market in 2024. This can be attributed to several factors such as the rising colorectum cancer cases, the presence of key market players, combined with significant advancements in product development and regulatory approvals, acting as key factors contributing to the growth of the anastomotic leak devices market in the North America region during the forecast period from 2025 to 2032.

According to data from the Global Cancer Observatory 2024, it stated that in the year 2022, there were 183,911 total colorectum cancer cases in the region. The same source further stated that the US accounted for 160,186 colorectum cancer cases which is almost 87% of the total cases, and Canada accounted for 23,725 colorectum cancer cases. Anastomotic leak devices are essential for reconnecting bowel segments during surgical resections. Advanced devices improve surgical precision, reduce complications, and enhance recovery, making them indispensable in managing colorectal cancer cases and expanding their market.

Additionally, in October 2024, GT Metabolic Solutions Inc., a global leader in magnetic compression anastomosis surgery, announced that the U.S. Food and Drug Administration cleared GT Metabolic's MagDI(TM) System for side-to-side duodeno-ileal (DI) anastomosis.

The prompt and well-established healthcare services and infrastructure further contribute to the growth of the regional anastomotic leak devices market growth. The presence of key players such as Johnson & Johnson Services, Inc., B.Braun Melsungen AG, and Medtronic with their strong distribution networks ensure widespread availability and accessibility of these devices across the region increasing their revenue shares in the market, and supportive reimbursement programs, providing immense growth opportunities for the same.

Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the anastomotic leak devices market during the forecast period from 2025 to 2032.

Anastomotic Leak Devices Market key players:

Some the key market players operating in the anastomotic leak devices market include Johnson & Johnson Services, Inc., Medtronic, Baxter, BD, 3M, Teleflex Incorporated, Integra LifeSciences, B.Braun Melsungen AG, Artivion, Stryker, Lydus Medical, GT Metabolic Solutions Inc., Vascular Graft Solutions Ltd., and others.

Recent Developmental Activities in the Anastomotic Leak Devices Market:

In April 2021, Ethicon announced the global launch of a new powered surgical stapler, with gripping surface technology.
In March 2021, Johnson & Johnson launched the ECHELON Stapler, a powered surgical stapler designed to reduce complications in surgery through more uniform tissue compression.
In February 2021, Vascular Graft Solutions Ltd. received marketing authorization from the FDA for VIOLA, a new device for clamp less proximal anastomosis in CABG.

Key takeaways from the Anastomotic Leak Devices market report study

Market size analysis for current Anastomotic Leak Devices market size (2024), and market forecast for 8 years (2025 to 2032)
Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the Anastomotic Leak Devices market
Various opportunities available for other competitors in the Anastomotic Leak Devices market space
What are the top-performing segments in 2024? How these segments will perform in 2032?
Which are the top-performing regions and countries in the current Anastomotic Leak Devices market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Anastomotic Leak Devices market growth in the coming future?

Target audience who can be benefited from this Anastomotic Leak Devices market report study

Anastomotic Leak Devices providers
Research organizations and consulting companies
Anastomotic Leak Devices-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and traders dealing in Anastomotic Leak Devices
Various end-users who want to know more about the Anastomotic Leak Devices market and the latest developments in the Anastomotic Leak Devices market

Frequently Asked Questions for the Anastomotic Leak Devices Market:

1. What are Anastomotic Leak Devices?

The anastomotic leak devices are medical tools or systems designed to prevent, detect, or treat leaks that occur at the site of a surgical anastomosis.

2. What is the market for Anastomotic Leak Devices?

The anastomotic leak devices market was valued at USD 3,442.84 million in 2024, growing at a CAGR of 5.59% during the forecast period from 2025 to 2032 to reach USD 5,294.62 million by 2032.

3. What are the drivers for the Anastomotic Leak Devices market?

The anastomotic leak devices market is growing significantly due to the increasing cases of colorectum cancers, coronary artery disease (CAD) among the population, clearances from regulatory bodies, and the growing number of gastrointestinal surgeries, among others that are expected to escalate the overall growth of the anastomotic leak devices market during the forecast period from 2025 to 2032.

4. Who are the key players operating in the Anastomotic Leak Devices market?

Some the key market players operating in the anastomotic leak devices market include Johnson & Johnson Services, Inc., Medtronic, Baxter, BD, 3M, Teleflex Incorporated, Integra LifeSciences, B.Braun Melsungen AG, Artivion, Stryker, Lydus Medical, GT Metabolic Solutions Inc., Vascular Graft Solutions Ltd., and others.

5. Which region has the highest share in the Anastomotic Leak Devices market?

Among all the regions, North America is estimated to hold a significant revenue share in the anastomotic leak devices market in 2024. This can be attributed to several factors such as the rising cases of colorectum cancers, the presence of key market players, combined with significant advancements in product developments and regulatory approvals that are acting as key factors contributing to the growth of the anastomotic leak devices market in the North America region during the forecast period from 2025 to 2032.

1. Anastomotic Leak Devices Market Report Introduction

1.1. Scope of the Study
1.2. Market Segmentation
1.3. Market Assumption

2. Anastomotic Leak Devices Market Executive Summary

2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

4.1. The United States
4.2. Europe
4.3. Japan
4.4. China

5. Anastomotic Leak Devices Market Key Factors Analysis

5.1. Anastomotic Leak Devices Market Drivers
- 5.1.1. Increasing number of chronic disorders
- 5.1.2. Rising product developmental activities
- 5.1.3. Growing number of gastrointestinal surgeries
5.2. Anastomotic Leak Devices Market Restraints and Challenges
- 5.2.1. Risk of post-operative complications such as tissue irritation, infection, or pressure necrosis
5.3. Anastomotic Leak Devices Market Opportunities
- 5.3.1. Growing adoption of robot-assisted surgery
- 5.3.2. Development of bioabsorbable materials

6. Anastomotic Leak Devices Market Porter's Five Forces Analysis

6.1. Bargaining Power of Suppliers
6.2. Bargaining Power of Consumers
6.3. Threat of New Entrants
6.4. Threat of Substitutes
6.5. Competitive Rivalry

7. Anastomotic Leak Devices Market Assessment

7.1. By Usability
- 7.1.1. Disposable
- 7.1.2. Reusable
7.2. By Application
- 7.2.1. Cardiovascular surgery
- 7.2.2. Gastrointestinal surgery
- 7.2.3. Others
7.3. By End-User
- 7.3.1. Hospitals
- 7.3.2. Speciality Clinics
- 7.3.3. Others
7.4. By Geography
- 7.4.1. North America
  - 7.4.1.1. United States Anastomotic Leak Devices Market Size in USD million (2022-2032)
  - 7.4.1.2. Canada Anastomotic Leak Devices Market Size in USD million (2022-2032)
  - 7.4.1.3. Mexico Anastomotic Leak Devices Market Size in USD million (2022-2032)
- 7.4.2. Europe
  - 7.4.2.1. France Anastomotic Leak Devices Market Size in USD million (2022-2032)
  - 7.4.2.2. Germany Anastomotic Leak Devices Market Size in USD million (2022-2032)
  - 7.4.2.3. United Kingdom Anastomotic Leak Devices Market Size in USD million (2022-2032)
  - 7.4.2.4. Italy Anastomotic Leak Devices market size in USD million (2022-2032)
  - 7.4.2.5. Spain Anastomotic Leak Devices Market Size in USD million (2022-2032)
  - 7.4.2.6. Rest of Europe Anastomotic Leak Devices Market Size in USD million (2022-2032)
- 7.4.3. Asia-Pacific
  - 7.4.3.1. China Anastomotic Leak Devices Market Size in USD million (2022-2032)
  - 7.4.3.2. Japan Anastomotic Leak Devices Market Size in USD million (2022-2032)
  - 7.4.3.3. India Anastomotic Leak Devices Market Size in USD million (2022-2032)
  - 7.4.3.4. Australia Anastomotic Leak Devices Market Size in USD million (2022-2032)
  - 7.4.3.5. South Korea Anastomotic Leak Devices Market Size in USD million (2022-2032)
  - 7.4.3.6. Rest of Asia-Pacific Anastomotic Leak Devices Market Size in USD million (2022-2032)
- 7.4.4. Rest of the World (RoW)
  - 7.4.4.1. Middle East Anastomotic Leak Devices Market Size in USD million (2022-2032)
  - 7.4.4.2. Africa Anastomotic Leak Devices Market Size in USD million (2022-2032)
  - 7.4.4.3. South America Anastomotic Leak Devices Market Size in USD million (2022-2032)

8. Anastomotic Leak Devices Market Company and Product Profiles

8.1. Johnson & Johnson Services, Inc.
- 8.1.1. Company Overview
- 8.1.2. Company Snapshot
- 8.1.3. Financial Overview
- 8.1.4. Product Listing
- 8.1.5. Entropy
8.2. Medtronic
- 8.2.1. Company Overview
- 8.2.2. Company Snapshot
- 8.2.3. Financial Overview
- 8.2.4. Product Listing
- 8.2.5. Entropy
8.3. Baxter
- 8.3.1. Company Overview
- 8.3.2. Company Snapshot
- 8.3.3. Financial Overview
- 8.3.4. Product Listing
- 8.3.5. Entropy
8.4. BD
- 8.4.1. Company Overview
- 8.4.2. Company Snapshot
- 8.4.3. Financial Overview
- 8.4.4. Product Listing
- 8.4.5. Entropy
8.5. 3M
- 8.5.1. Company Overview
- 8.5.2. Company Snapshot
- 8.5.3. Financial Overview
- 8.5.4. Product Listing
- 8.5.5. Entropy
8.6. Teleflex Incorporated
- 8.6.1. Company Overview
- 8.6.2. Company Snapshot
- 8.6.3. Financial Overview
- 8.6.4. Product Listing
- 8.6.5. Entropy
8.7. Integra LifeSciences
- 8.7.1. Company Overview
- 8.7.2. Company Snapshot
- 8.7.3. Financial Overview
- 8.7.4. Product Listing
- 8.7.5. Entropy
8.8. B.Braun Melsungen AG
- 8.8.1. Company Overview
- 8.8.2. Company Snapshot
- 8.8.3. Financial Overview
- 8.8.4. Product Listing
- 8.8.5. Entropy
8.9. Artivion
- 8.9.1. Company Overview
- 8.9.2. Company Snapshot
- 8.9.3. Financial Overview
- 8.9.4. Product Listing
- 8.9.5. Entropy
8.10. Stryker
- 8.10.1. Company Overview
- 8.10.2. Company Snapshot
- 8.10.3. Financial Overview
- 8.10.4. Product Listing
- 8.10.5. Entropy
8.11. Lydus Medical
- 8.11.1. Company Overview
- 8.11.2. Company Snapshot
- 8.11.3. Financial Overview
- 8.11.4. Product Listing
- 8.11.5. Entropy
8.12. GT Metabolic Solutions Inc.
- 8.12.1. Company Overview
- 8.12.2. Company Snapshot
- 8.12.3. Financial Overview
- 8.12.4. Product Listing
- 8.12.5. Entropy
8.13. Vascular Graft Solutions Ltd.
- 8.13.1. Company Overview
- 8.13.2. Company Snapshot
- 8.13.3. Financial Overview
- 8.13.4. Product Listing
- 8.13.5. Entropy